Proto Labs, Inc. — 2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014. This is an annual filing, not a standalone Q4 report; quarterly figures below are unaudited. Proto Labs provides quick-turn custom parts through injection molding (Protomold), CNC machining (Firstcut), and additive manufacturing (Fineline).
Financial performance
| Metric | FY 2014 | FY 2013 | Change |
|---|---|---|---|
| Revenue | $209.6 million | $163.1 million | +28.5% |
| Gross profit / margin | $128.4 million / 61.3% | $101.7 million / 62.4% | Margin down 1.1 points |
| Operating income / margin | $60.5 million / 28.9% | $51.3 million / 31.5% | Income +18.0% |
| Net income / diluted EPS | $41.6 million / $1.60 | $35.3 million / $1.36 | Income +18.0% |
| Operating cash flow | $57.2 million | $48.4 million | +$8.8 million |
- FY 2014 revenue by product line: Protomold $140.3 million, Firstcut $59.9 million, and Fineline $9.4 million. The United States generated $156.0 million; international markets generated $53.6 million, or 25.6% of revenue.
- Q4 2014 revenue was $56.1 million, operating income $14.7 million, net income $10.2 million, and diluted EPS $0.39. Revenue increased from $44.0 million in Q4 2013; quarterly gross margin was 59.9%, versus 62.7% a year earlier.
- At year-end, cash and cash equivalents were $43.3 million and marketable securities totaled $85.0 million. Working capital was $89.6 million. Total liabilities were $22.0 million, including $0.1 million of capital-lease debt; the filing reports no material conventional borrowing balance.
- Investing cash outflow was $63.5 million, including $43.5 million of property and equipment purchases and $33.9 million of net cash used for acquisitions, partly offset by marketable-security maturities. Capital spending expanded manufacturing capacity.
Material changes and unusual items
- Revenue growth reflected higher sales volumes, expanded sales and marketing, and the April 2014 FineLine acquisition. Protomold revenue rose 21.9% and Firstcut 24.7%; Fineline contributed $9.4 million from the acquisition date.
- FineLine was acquired for $33.9 million net cash consideration plus contingent consideration, bringing total purchase consideration to approximately $36.9 million. The purchase accounting recorded $28.9 million of goodwill and $4.6 million of acquired intangible assets.
- Gross margin declined as Fineline had lower margins than legacy product lines and newly added capacity was not fully utilized. Operating expenses rose 34.7%, faster than revenue, with higher staffing and investment in sales, R&D, and administration; R&D expense increased 40.0% to $16.6 million.
- Average revenue per product developer or engineer decreased 4% in 2014, even as the number served increased. International revenue was negatively affected by approximately $0.1 million from currency movements.
Outlook, risks, and contingencies
- Management expects to continue investing in technology, personnel, manufacturing capacity, sales, and marketing. It expects cost of revenue to rise in dollars and remain relatively constant as a share of revenue over time; future capital expenditures, excluding building purchases, were estimated at 8%–12% of annual revenue. No specific revenue or earnings guidance was provided.
- Management believed cash, investments, and operating cash generation would be sufficient for working-capital and capital needs for at least 12 months. It also noted additional capital may be required and might not be available on acceptable terms.
- Key risks include intensifying competition and rapid technological change; maintaining quote and production speed, pricing, quality, and capacity as the business grows; customer adoption of e-commerce and 3D CAD; system outages and cybersecurity; reliance on limited-source suppliers; international and foreign-exchange exposure; and acquisition integration.
- The company does not hedge foreign-currency exposure. Management stated a hypothetical 10% adverse currency move was not expected to have a material impact, but currency effects can adversely affect results. Foreign-held cash was $10.1 million; management intended to reinvest it abroad, and repatriation could incur U.S. taxes.
- The company reported no litigation expected to have a material adverse effect. It recorded $1.3 million of liabilities for unrecognized tax benefits. Independent auditors gave unqualified opinions on the financial statements and internal control; FineLine controls representing about 3% of assets and 5% of revenue were excluded from the 2014 internal-control assessment.
Important facts for investors to verify
- Whether Fineline’s revenue growth and margins improve, and whether acquisition integration delivers expected benefits.
- Whether gross and operating margins recover as added capacity is utilized, given that expenses grew faster than revenue in 2014.
- Cash conversion and investment requirements, including the scale and returns of manufacturing-capacity spending.
- Customer growth and repeat business alongside the decline in average revenue per developer or engineer.
- Foreign-exchange exposure, the treatment of foreign-held cash, tax contingencies, and the eventual integration of FineLine’s financial controls.